FDA clears in vivo blood stem cell editing trial; Abeona's $155M PRV sale

Plus, news about CytomX, Valneva, Lenz and Lotus Pharmaceutical:

Related Posts

How Illumina’s ex-employees became its customers and co...

May 29, 2025  0

Biotech downturn exposes startups to big lease liabilities

May 21, 2025  0

AI biotech Xaira unveils virtual cell research paper

Jun 17, 2025  0

Comments

Name

Email

Comment

Post Comment